Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Callan Jmb (CJMB) Cash & Equivalents (2023 - 2025)

Callan Jmb (CJMB) has disclosed Cash & Equivalents for 3 consecutive years, with $2.8 million as the latest value for Q3 2025.

  • Quarterly Cash & Equivalents changed N/A to $2.8 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $2.8 million through Sep 2025, changed N/A year-over-year, with the annual reading at $2.1 million for FY2024, 59.31% down from the prior year.
  • Cash & Equivalents hit $2.8 million in Q3 2025 for Callan Jmb, down from $4.2 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $5.2 million in Q1 2025 to a low of $2.1 million in Q4 2024.
  • Historically, Cash & Equivalents has averaged $3.9 million across 3 years, with a median of $4.2 million in 2025.
  • Biggest YoY gain for Cash & Equivalents was 59.31% in 2024; the steepest drop was 59.31% in 2024.
  • Year by year, Cash & Equivalents stood at $5.2 million in 2023, then plummeted by 59.31% to $2.1 million in 2024, then soared by 32.98% to $2.8 million in 2025.
  • Business Quant data shows Cash & Equivalents for CJMB at $2.8 million in Q3 2025, $4.2 million in Q2 2025, and $5.2 million in Q1 2025.